PNEUMONITIS AS A COMPLICATION OF IMMUNOTHERAPY OF ONCOLOGICAL DISEASES. DIFFICULTIES IN DIAGNOSIS AND TREATMENT

Pneumonitis is one of the complications of cancer immunotherapy. Despite its low incidence, it has a significant impact not only on the quality of life of patients, but also on mortality. Many foreign and domestic studies have been conducted to identify and treat pneumonitis, but most of them are narrow in nature. Due to the fact that immunotherapy is becoming increasingly popular, the number of complications will also increase. Since patients are observed not only in oncology institutions, there is a need for information for doctors of different profiles. And since pneumonitis is a life-threatening complication, it is very important to maintain a high index of suspicion in order to identify it at an early stage and prescribe treatment. In our article, we have combined and systematized data from different sources, focusing on diagnostics and therapy.